Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 57, Issue 2, Pages 557-573
Publisher
IOS Press
Online
2017-03-06
DOI
10.3233/jad-160216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities
- (2013) Wagner Zago et al. Alzheimers & Dementia
- An MRI Rating Scale for Amyloid-Related Imaging Abnormalities with Edema or Effusion
- (2013) F. Barkhof et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- MR Imaging Features of Amyloid-Related Imaging Abnormalities
- (2013) J. Barakos et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Clearance of Amyloid-ß Protein Deposits in Transgenic Mice following Focal Cerebral Ischemia
- (2012) W.E. Van Nostrand et al. Neurodegenerative Diseases
- Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab
- (2011) Christopher Carlson et al. Alzheimers & Dementia
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Cerebral Amyloid Angiopathy: A Systematic Review
- (2011) Alessandro Biffi et al. Journal of Clinical Neurology
- Cerebral microhemorrhage and brain -amyloid in aging and Alzheimer disease
- (2011) P. A. Yates et al. NEUROLOGY
- Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
- (2011) Todd E. Golde et al. NEURON
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Murine models of Alzheimer's disease and their use in developing immunotherapies
- (2010) Thomas Wisniewski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Improving Interrater Agreement About Brain Microbleeds
- (2008) Charlotte Cordonnier et al. STROKE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now